Wells Fargo & Company/mn
Market Movers (8-K)
NYSE
Wells Fargo & Company announced robust second quarter 2026 financial results, with net income reaching $6.4 billion, or $2.00 per diluted share, marking a significant year-over-year increase.
NYSE
Wells Fargo & Company has issued $6 billion in aggregate principal amount of Senior Medium-Term Notes, Series Y, across three tranches.
Capital raise
NYSE
Wells Fargo shareholders approved the amendment and restatement of the 2022 Long-Term Incentive Plan and elected 12 directors at the 2026 annual meeting.
NYSE
Wells Fargo & Company announced first quarter 2026 net income of $5.3 billion, or $1.60 per diluted share, demonstrating growth across its business segments.
NYSE
Wells Fargo & Company has formally eliminated the Certificate of Designation for its 3.90% Fixed Rate Reset Non-Cumulative Perpetual Class A Preferred Stock, Series BB, following the redemption of all 140,400 outstanding shares.
Delay expected
NYSE
Wells Fargo & Company announced the full redemption of its 3.90% Fixed Rate Reset Non-Cumulative Perpetual Class A Preferred Stock, Series BB, and related depositary shares.
Delay expected
Quarterly Earnings (10-Q)
NYSE
Wells Fargo & Company announced robust financial results for the second quarter of 2026, with net income and diluted EPS significantly increasing year-over-year.
NYSE
Wells Fargo & Company announced its first quarter 2026 financial results, reporting a net income of $5.3 billion, a 7% increase year-over-year.
NYSE
Wells Fargo reported a 9% increase in net income for the third quarter of 2025, driven by higher revenue and improved credit quality, while maintaining robust capital and liquidity.
Capital raise
Better than expected
NYSE
Wells Fargo reported a significant increase in second quarter net income and diluted earnings per share, alongside the Federal Reserve's removal of its asset growth limitation.
Better than expected
Capital raise
NYSE
Wells Fargo's Q1 2025 earnings reveal a $4.9 billion net income, bolstered by decreased noninterest and income tax expenses despite a slight revenue dip.
Better than expected
NYSE
Wells Fargo's Q3 2024 earnings saw a decrease in net income compared to the previous year, influenced by lower net interest income and ongoing regulatory challenges.
Worse than expected
Delay expected
Annual Reports (10-K)
NYSE
Wells Fargo & Company announced a significant increase in net income and diluted earnings per share for 2025, alongside the removal of its asset growth limitation by the Federal Reserve Board.
Capital raise
Better than expected
NYSE
Wells Fargo's 2024 10-K filing reveals a complex interplay of regulatory compliance, economic pressures, and strategic initiatives shaping the financial giant's performance.
NYSE
This document provides a detailed description of Wells Fargo's common stock, preferred stock, and depositary shares, as well as the guarantee of medium-term notes.
Insider Trading (Form 4)
NYSE
Derek A. Flowers, Sr. EVP and Chief Risk Officer of Wells Fargo & Company/Mn, reported multiple transactions in common stock on July 15, 2026.
NYSE
Wells Fargo & Company Director Wayne M. Hewett reported a transaction involving phantom stock units, converting them into common stock.
NYSE
Wells Fargo executive Jason M. Rosenberg reported the vesting and subsequent sale of restricted share rights, totaling over 17,000 shares.
NYSE
Wells Fargo & Company reported the redemption of 750 MuniFund Preferred Shares from the Nuveen Quality Municipal Income Fund.
NYSE
Theodore F. Craver Jr., a Director at Wells Fargo & Company, reported transactions involving the acquisition and disposition of common stock.
NYSE
Wells Fargo director Suzanne M. Vautrinot acquired 3,436 common stock units as part of a routine equity compensation grant.
Proxy Statements (Def-14A)
NYSE
Wells Fargo & Company has filed a definitive proxy statement with the SEC.
NYSE
Wells Fargo's 2025 Annual Meeting of Shareholders will be held virtually on April 29, 2025, featuring votes on director elections, executive compensation, auditor ratification, and shareholder proposals.
NYSE
Wells Fargo details its shareholder engagement efforts and responsive actions following the 2023 Annual Meeting in its Spring 2024 Investor Presentation.
NYSE
Wells Fargo & Company has filed a definitive proxy statement with the Securities and Exchange Commission.
NYSE
DEF 14A: Wells Fargo's 2024 Proxy Statement Reveals Board Nominees, Executive Pay, and Governance Proposals
Wells Fargo's 2024 proxy statement outlines key agenda items for the annual shareholder meeting, including director elections, executive compensation, and proposed amendments to corporate governance documents.
Institutional Holdings (13F)
NYSE
Wells Fargo & Company/MN has filed its Q2 2025 13F-HR report, revealing a substantial equity portfolio valued at over $483 billion across 17,891 positions.
NYSE
Wells Fargo & Company's latest 13F filing reveals their significant holdings as of March 31, 2025, totaling over $440 billion across thousands of positions.
NYSE
Wells Fargo & Company's latest 13F filing discloses a diverse range of holdings valued at over $443 billion as of December 31, 2024.
NYSE
Wells Fargo & Company's latest 13F filing discloses a diverse portfolio of equity holdings valued at over $441 billion.
NYSE
Wells Fargo & Company's 13F filing for Q2 2024 reveals a substantial portfolio with a total value of over $412 billion across 17,489 holdings.
NYSE
Wells Fargo & Company's latest 13F filing discloses its portfolio holdings as of March 31, 2024, showcasing significant investments across various sectors.
Schedule 13D - Activist Investments
NYSE
Wells Fargo & Company reports a reduction in its holdings of Nuveen Quality Municipal Income Fund preferred shares following a redemption.
NYSE
SCHEDULE: Nuveen Fund Reorganization Update
Wells Fargo entities report no longer holding preferred shares in Nuveen New Jersey Quality Municipal Income Fund following a reorganization into NMZ.
NYSE
Wells Fargo & Company and its affiliate report a significant stake in Nuveen Municipal High Income Opportunity Fund following a corporate reorganization.
NYSE
SCHEDULE: Nuveen Fund Reorganization Update
Wells Fargo & Company and its affiliate report no longer owning VRDP Shares of Nuveen Pennsylvania Quality Municipal Income Fund following a reorganization.
NYSE
Wells Fargo reports a planned redemption of 500 MuniFund Preferred Shares by Nuveen Quality Municipal Income Fund, reducing its beneficial ownership.
NYSE
Wells Fargo & Company and its affiliate have fully redeemed their Variable Rate MuniFund Term Preferred Shares in AllianceBernstein National Municipal Income Fund, Inc.
Schedule 13G - Passive Investments
NYSE
Wells Fargo & Company has reported a 6.6% beneficial ownership in RiverNorth/DoubleLine Strategic Opp Fund's common stock as of June 30, 2026.
NYSE
Wells Fargo & Company has filed a Schedule 13G, reporting beneficial ownership of 931,846 shares, representing 6.8% of Ellsworth Growth and Income's Common Shares of Beneficial Interest.
NYSE
Wells Fargo & Company has filed a Schedule 13G, reporting beneficial ownership of 3,913,997 shares, representing 5.1% of the outstanding common shares of beneficial interest in BlackRock Resources & Commdty.
NYSE
Wells Fargo & Company has filed a Schedule 13G, reporting beneficial ownership of 870,926 shares, representing 6.7% of the class, in BlackRock MuniYield PA Quality.
NYSE
Wells Fargo & Company has reported a beneficial ownership of 1,913,094 common shares, representing 8.3% of the class, in the Ares Dynamic Credit Allocation Fund.
NYSE
Wells Fargo & Company has filed a Schedule 13G, reporting beneficial ownership of 947,639 shares, representing 6.9% of Ellsworth Growth and Income's common shares.